
HSBC – Dear Customer
Financial crime evolves, and HSBC wants to help keep you safe.
The FDA sent a warning letter to Graviola Group in April 2014 for selling its Graviola Extract without FDA approval in violation of the FDA regulations. According to the FDA’s letter, the company claims that Graviola Extract can cure, treat, or prevent cancer. On its website, the company says Graviola Extract:
In addition, the FDA also warned the company that Graviola Extract is mislabeled because it does not include adequate instructions.
Graviola Group had 15 days to correct the issues and respond to the FDA.
For more information about the misleading marketing of supplements, click here.
Financial crime evolves, and HSBC wants to help keep you safe.
Be wary of this supplement’s FDA claims.
MADISON, CONN. June 22, 2022 While millions of Americans struggle with rising food prices and empty store shelves, meal kit retailer HelloFresh advertises “delicious meals delivered to your door,” enticing consumers…